Aarey Drugs [AAREYDRUGS] vs Biofil Chemicals [BIOFILCHEM] Detailed Stock Comparison

Aarey Drugs

NSE
Loading...

Biofil Chemicals

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Aarey Drugs wins in 9 metrics, Biofil Chemicals wins in 10 metrics, with 0 ties. Biofil Chemicals appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAarey DrugsBiofil ChemicalsBetter
P/E Ratio (TTM)57.1423.70Biofil Chemicals
Price-to-Book Ratio1.703.61Aarey Drugs
Debt-to-Equity Ratio25.172.51Biofil Chemicals
PEG Ratio6.290.02Biofil Chemicals
EV/EBITDA85.8718.00Biofil Chemicals
Profit Margin (TTM)0.93%8.19%Biofil Chemicals
Operating Margin (TTM)1.19%31.74%Biofil Chemicals
EBITDA Margin (TTM)1.19%31.74%Biofil Chemicals
Return on Equity2.91%2.97%Biofil Chemicals
Return on Assets (TTM)1.39%1.09%Aarey Drugs
Free Cash Flow (TTM)$50.96M$-20.24MAarey Drugs
1-Year Return35.11%-45.71%Aarey Drugs
Price-to-Sales Ratio (TTM)0.531.95Aarey Drugs
Enterprise Value$2.42B$666.16MAarey Drugs
EV/Revenue Ratio0.541.95Aarey Drugs
Gross Profit Margin (TTM)4.28%6.89%Biofil Chemicals
Revenue per Share (TTM)$160$21Aarey Drugs
Earnings per Share (Diluted)$1.47$1.72Biofil Chemicals
Beta (Stock Volatility)0.520.97Aarey Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Aarey Drugs vs Biofil Chemicals Stock Performance Analysis

Loading Price Chart...

Aarey Drugs
Biofil Chemicals
Aarey Drugs Stock Overview | Biofil Chemicals Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Aarey Drugs-1.19%1.40%17.96%18.36%85.51%46.04%
Biofil Chemicals-1.23%-2.11%-4.14%-11.93%-5.12%-32.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Aarey Drugs35.11%112.12%93.77%93.77%93.77%93.77%
Biofil Chemicals-45.71%-15.26%-46.26%77.60%77.60%77.60%

News Based Sentiment: Aarey Drugs vs Biofil Chemicals

Aarey Drugs

News based Sentiment: MIXED

October brought a mixed bag of results for Aarey Drugs & Pharmaceuticals, with increased profitability but declining revenues. Share price fluctuations and changes in shareholding add complexity to the investment picture, making it a moderately significant month for investors.

View Aarey Drugs News Sentiment Analysis

Biofil Chemicals

News based Sentiment: MIXED

October presented a complex picture for Biofil Chemicals, with initial positive momentum from a deal announcement and 52-week high being significantly countered by substantial declines in revenue and profitability reported in its Q1 and Q2 2025 results. This creates a mixed investment narrative requiring careful consideration.

View Biofil Chemicals News Sentiment Analysis

Performance & Financial Health Analysis: Aarey Drugs vs Biofil Chemicals

MetricAAREYDRUGSBIOFILCHEM
Market Information
Market Cap i₹2.36B₹657.10M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i72,02629,517
90 Day Avg. Volume i58,62714,813
Last Close₹83.00₹40.26
52 Week Range₹32.85 - ₹84.00₹40.11 - ₹79.70
% from 52W High-1.19%-49.49%
All-Time High₹84.00 (Oct 07, 2025)₹356.10 (Dec 14, 2020)
% from All-Time High-1.19%-88.69%
Growth Metrics
Quarterly Revenue Growth-0.20%0.09%
Quarterly Earnings Growth0.11%13.24%
Financial Health
Profit Margin (TTM) i0.01%0.08%
Operating Margin (TTM) i0.01%0.32%
Return on Equity (TTM) i0.03%0.03%
Debt to Equity (MRQ) i25.172.51
Cash & Liquidity
Book Value per Share (MRQ)₹49.36₹11.29
Cash per Share (MRQ)₹1.29₹0.16
Operating Cash Flow (TTM) i₹366.06M₹-55,788,000
Levered Free Cash Flow (TTM) i₹40.24M₹5.58M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Aarey Drugs vs Biofil Chemicals

MetricAAREYDRUGSBIOFILCHEM
Price Ratios
P/E Ratio (TTM) i57.1423.70
Forward P/E iN/AN/A
PEG Ratio i6.290.02
Price to Sales (TTM) i0.531.95
Price to Book (MRQ) i1.703.61
Market Capitalization
Market Capitalization i₹2.36B₹657.10M
Enterprise Value i₹2.42B₹666.16M
Enterprise Value Metrics
Enterprise to Revenue i0.541.95
Enterprise to EBITDA i85.8718.00
Risk & Other Metrics
Beta i0.520.97
Book Value per Share (MRQ) i₹49.36₹11.29

Financial Statements Comparison: Aarey Drugs vs Biofil Chemicals

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AAREYDRUGSBIOFILCHEM
Revenue/Sales i₹1.02B₹64.33M
Cost of Goods Sold i₹978.36M₹59.90M
Gross Profit i₹43.73M₹4.43M
Research & Development iN/AN/A
Operating Income (EBIT) i₹12.17M₹-602,000
EBITDA i₹32.54M₹28.38M
Pre-Tax Income i₹17.28M₹27.63M
Income Tax i₹3.57M₹3.52M
Net Income (Profit) i₹13.71M₹24.11M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AAREYDRUGSBIOFILCHEM
Cash & Equivalents i₹14.73M₹2.55M
Total Current Assets i₹2.66B₹425.54M
Total Current Liabilities i₹1.49B₹318.48M
Long-Term Debt i₹19.87MN/A
Total Shareholders Equity i₹1.38B₹187.81M
Retained Earnings i₹571.32M₹-311.16M
Property, Plant & Equipment i₹1.96M₹2.43M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AAREYDRUGSBIOFILCHEM
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAAREYDRUGSBIOFILCHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i72,02629,517
Average Daily Volume (90 Day) i58,62714,813
Shares Outstanding i28.45M16.27M
Float Shares i9.96M7.25M
% Held by Insiders i0.51%0.59%
% Held by Institutions i0.02%0.00%

Dividend Analysis & Yield Comparison: Aarey Drugs vs Biofil Chemicals

MetricAAREYDRUGSBIOFILCHEM
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A